Page last updated: 2024-09-03

4,4-dicarboxy-5-pyridoxylproline and eticlopride

4,4-dicarboxy-5-pyridoxylproline has been researched along with eticlopride in 1 studies

Compound Research Comparison

Studies
(4,4-dicarboxy-5-pyridoxylproline)
Trials
(4,4-dicarboxy-5-pyridoxylproline)
Recent Studies (post-2010)
(4,4-dicarboxy-5-pyridoxylproline)
Studies
(eticlopride)
Trials
(eticlopride)
Recent Studies (post-2010) (eticlopride)
904378195

Protein Interaction Comparison

ProteinTaxonomy4,4-dicarboxy-5-pyridoxylproline (IC50)eticlopride (IC50)
D(2) dopamine receptorMus musculus (house mouse)0.0009
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banala, AK; Beuming, T; Cao, J; Donthamsetti, P; Javitch, JA; LaBounty, A; Levy, B; Luedtke, RR; Michino, M; Newman, AH; Pongetti, K; Shi, L1

Other Studies

1 other study(ies) available for 4,4-dicarboxy-5-pyridoxylproline and eticlopride

ArticleYear
Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.
    Journal of medicinal chemistry, 2012, Aug-09, Volume: 55, Issue:15

    Topics: Computer Simulation; HEK293 Cells; Humans; Molecular Conformation; Molecular Dynamics Simulation; Piperazines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Static Electricity; Structure-Activity Relationship

2012